VIA
LEGN icon

Vident Investment Advisory’s Legend Biotech LEGN Stock Holding History

Vident Investment Advisory’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,260
Closed -$784K – 1281
2023
Q1 		$784K Sell
16,260
-391
-2% -$19.1K 0.03% 604
2022
Q4 		$831K Sell
16,651
-294
-2% -$14.2K 0.03% 535
2022
Q3 		$666K Sell
16,945
-1,921
-10% -$90.2K 0.02% 701
2022
Q2 		$1.04M Sell
18,866
-11,129
-37% -$470K 0.03% 607
2022
Q1 		$1.09M Buy
29,995
+2,952
+11% +$117K 0.03% 662
2021
Q4 		$1.26M Sell
27,043
-14,169
-34% -$719K 0.03% 622
2021
Q3 		$2.08M Sell
41,212
-6,444
-14% -$268K 0.06% 386
2021
Q2 		$1.96M Sell
47,656
-19,833
-29% -$674K 0.06% 416
2021
Q1 		$1.96M Buy
67,489
+2,327
+4% +$63.5K 0.07% 386
2020
Q4 		$1.83M Buy
65,162
+23,489
+56% +$676K 0.07% 318
2020
Q3 		$1.29M Buy
41,673
+4,938
+13% +$166K 0.06% 416
2020
Q2 		$1.56M Buy
+36,735
New +$1.44M 0.08% 292

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vident Investment Advisory's LEGN Position: Q2 2023 in Review

Vident Investment Advisory sold out of Legend Biotech (LEGN) in Q2 2023, closing a stake of 16,260 shares — an estimated $784K sold.

Vident Investment Advisory first reported a position in LEGN in Q2 2020 and held it in 12 quarters. The position peaked at $2.08M in Q3 2021. 194 funds tracked by Wall St. Rank hold LEGN as of Q2 2023.

  • Vident Investment Advisory reported no remaining Legend Biotech position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 16,260 Legend Biotech shares in Q2 2023, an estimated $784K.
  • Vident Investment Advisory first reported a position in Legend Biotech in Q2 2020 and held it in 12 quarters.
  • Vident Investment Advisory's Legend Biotech position peaked at $2.08M in Q3 2021.
  • 194 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.